NOS2 and systemic sclerosis: For example, increased iNOS expression in the lungs has been associated with induced proliferation and activation of human pulmonary fibroblasts (3, 30, 31) and is positively correlated with disease severity in patients with IPF and systemic sclerosis (31, 32).